Interstitial lung disease before and after COVID-19: a double threat?

Pre-existing ILD and pulmonary fibrosis increases the risk to manifest severe COVID-19. Residual interstitial lung changes and sequelae have been observed in COVID-19 survivors. A closer and standardised long-term follow-up of these patients is needed. https://bit.ly/3jWBPCG

Detalles Bibliográficos
Autores principales: Valenzuela, Claudia, Waterer, Grant, Raghu, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637181/
https://www.ncbi.nlm.nih.gov/pubmed/34857587
http://dx.doi.org/10.1183/13993003.01956-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637181/
https://www.ncbi.nlm.nih.gov/pubmed/34857587
http://dx.doi.org/10.1183/13993003.01956-2021

Ejemplares similares